Urvi M Parikh, PhD, Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
Presented by: Urvi M Parikh, PhD, Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine

Available on demand

The ability to accurately and rapidly evaluate SARS-CoV-2 NT50 has important applications for research​, including evaluation of prophylactic vaccines in immunocompromised adults​, assessment of potential protective efficacy of prophylactic monoclonal antibodies​, and monitoring of COVID-19 severity. In this webinar, we will show you how the Bio-Plex Pro Human SARS-CoV-2 Neutralization Antibody Assay could provide a rapid, high-throughput, culture-free method for NT50 determination in sera for current and future SARS-CoV-2 variants.

Watch Webinar
Tags:,,,
Previous post

Genotype Screening in Songbirds Made Easy

Next post

mAb Purification Process Development Using Mixed-Mode Resins — The DOE Approach